1. Home
  2. RDZN vs COEP Comparison

RDZN vs COEP Comparison

Compare RDZN & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDZN
  • COEP
  • Stock Information
  • Founded
  • RDZN 2015
  • COEP 2017
  • Country
  • RDZN United States
  • COEP United States
  • Employees
  • RDZN 308
  • COEP N/A
  • Industry
  • RDZN Blank Checks
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RDZN Finance
  • COEP Health Care
  • Exchange
  • RDZN Nasdaq
  • COEP Nasdaq
  • Market Cap
  • RDZN 74.5M
  • COEP 62.4M
  • IPO Year
  • RDZN N/A
  • COEP N/A
  • Fundamental
  • Price
  • RDZN $0.99
  • COEP $13.01
  • Analyst Decision
  • RDZN Strong Buy
  • COEP
  • Analyst Count
  • RDZN 2
  • COEP 0
  • Target Price
  • RDZN $5.00
  • COEP N/A
  • AVG Volume (30 Days)
  • RDZN 214.0K
  • COEP 44.5K
  • Earning Date
  • RDZN 11-12-2025
  • COEP 11-12-2025
  • Dividend Yield
  • RDZN N/A
  • COEP N/A
  • EPS Growth
  • RDZN N/A
  • COEP N/A
  • EPS
  • RDZN N/A
  • COEP N/A
  • Revenue
  • RDZN $46,230,126.00
  • COEP $263,555.00
  • Revenue This Year
  • RDZN $38.45
  • COEP N/A
  • Revenue Next Year
  • RDZN $66.38
  • COEP N/A
  • P/E Ratio
  • RDZN N/A
  • COEP N/A
  • Revenue Growth
  • RDZN N/A
  • COEP N/A
  • 52 Week Low
  • RDZN $0.68
  • COEP $2.31
  • 52 Week High
  • RDZN $2.99
  • COEP $14.70
  • Technical
  • Relative Strength Index (RSI)
  • RDZN 45.76
  • COEP 55.25
  • Support Level
  • RDZN $0.93
  • COEP $12.09
  • Resistance Level
  • RDZN $1.00
  • COEP $13.53
  • Average True Range (ATR)
  • RDZN 0.06
  • COEP 0.74
  • MACD
  • RDZN 0.00
  • COEP -0.14
  • Stochastic Oscillator
  • RDZN 55.63
  • COEP 53.57

About RDZN Roadzen Inc.

Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: